Loading
DC
Dyax Corp Stock: price and insider trades · United States
Dyax Corp: what insiders have been doing
This page follows insider dealings at Dyax Corp as filed with SEC (Form 4). Dyax Corp has had no insider filing for more than a year; the last one goes back to 22 January 2016.
For comparison within the same market, see the insider buying recorded at Relmada Therapeutics, Inc. and Uber Technologies, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
85
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
18 ops. · all time
Financial data
as of FY 2014FY ended December 2014 · cache
Income statement
RevenueUS$70.7M
Net income-US$10.3M-14.5% margin
Last declaration on 22 January 2016
Declarations85 total
208,602 sharesCommon StockSEC:0000908662-16-000425:0
331,528 sharesCommon StockSEC:0000908662-16-000426:0
1,016,762 sharesCommon StockSEC:0000908662-16-000428:0
100 sharesCommon StockSEC:0000908662-16-000428:1
13,750 sharesCommon StockSEC:0000908662-16-000427:0
2,447,622 sharesCommon StockSEC:0000908662-16-000430:0
200,970 sharesCommon StockSEC:0000908662-16-000432:0
232,440 sharesCommon StockSEC:0000908662-16-000433:0
55,041 sharesCommon StockSEC:0000908662-16-000434:0
539,805 sharesCommon StockSEC:0000908662-16-000434:1
997,336 sharesCommon StockSEC:0000908662-16-000434:2
5,021 sharesCommon StockSEC:0000908662-16-000434:3
131,305 sharesCommon StockSEC:0000908662-16-000435:0
137,433 sharesCommon StockSEC:0000908662-16-000436:0
751,975 sharesCommon StockSEC:0000908662-16-000437:0
15,000 sharesCommon StockSEC:0000908662-16-000437:1
80,000 sharesCommon StockSEC:0000908662-16-000438:0
6,000 sharesCommon StockSEC:0000908662-16-000402:0
75,000 sharesCommon StockSEC:0000908662-16-000402:1
75,000 sharesCommon StockSEC:0000908662-16-000402:2
8,107 sharesCommon StockSEC:0000908662-16-000402:3
25 of 85 declarations
About Dyax Corp
Dyax Corp is a company listed on the XNAS market, focused on developing treatments for rare diseases. It primarily concentrates on therapies for hereditary angioedema disorders.
